Drug factory · FDA FEI 3012279978
Celltrion Pharm, Inc
82 2sandan-ro, Ochang-eup, Cheongwon-gu, Cheongju, South Korea
Problems found, fixed voluntarily at FDA's last inspection, Jul 23, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2024: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Aflibercept | Packages it | CELLTRION USA, Inc. | 72606-026 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 23, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.